Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 3/10

vs
industry
vs
history
Cash-to-Debt No Debt
SKLN's Cash-to-Debt is ranked higher than
82% of the 172 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. SKLN: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
SKLN' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.09 Max: No Debt
Current: No Debt
Equity-to-Asset 0.33
SKLN's Equity-to-Asset is ranked lower than
80% of the 168 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.59 vs. SKLN: 0.33 )
Ranked among companies with meaningful Equity-to-Asset only.
SKLN' s Equity-to-Asset Range Over the Past 10 Years
Min: -8.93  Med: -6.06 Max: 0.73
Current: 0.33
-8.93
0.73
Piotroski F-Score: 4
Altman Z-Score: -26.22
Beneish M-Score: -6.08
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -1428.01
SKLN's Operating Margin % is ranked lower than
95% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.65 vs. SKLN: -1428.01 )
Ranked among companies with meaningful Operating Margin % only.
SKLN' s Operating Margin % Range Over the Past 10 Years
Min: -18075  Med: -1907.48 Max: -679.31
Current: -1428.01
-18075
-679.31
Net Margin % -1428.01
SKLN's Net Margin % is ranked lower than
95% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.23 vs. SKLN: -1428.01 )
Ranked among companies with meaningful Net Margin % only.
SKLN' s Net Margin % Range Over the Past 10 Years
Min: -18075  Med: -2009.83 Max: -717.86
Current: -1428.01
-18075
-717.86
ROE % -390.08
SKLN's ROE % is ranked lower than
99% of the 164 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.98 vs. SKLN: -390.08 )
Ranked among companies with meaningful ROE % only.
SKLN' s ROE % Range Over the Past 10 Years
Min: -390.08  Med: -259.12 Max: -259.12
Current: -390.08
-390.08
-259.12
ROA % -188.58
SKLN's ROA % is ranked lower than
98% of the 173 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.97 vs. SKLN: -188.58 )
Ranked among companies with meaningful ROA % only.
SKLN' s ROA % Range Over the Past 10 Years
Min: -1953.48  Med: -593.42 Max: -146.67
Current: -188.58
-1953.48
-146.67
ROC (Joel Greenblatt) % -5340.43
SKLN's ROC (Joel Greenblatt) % is ranked lower than
99% of the 171 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.87 vs. SKLN: -5340.43 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
SKLN' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -159177.78  Med: -13941.67 Max: -2619.05
Current: -5340.43
-159177.78
-2619.05
3-Year Revenue Growth Rate -69.60
SKLN's 3-Year Revenue Growth Rate is ranked lower than
98% of the 147 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.20 vs. SKLN: -69.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
SKLN' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: -37.9 Max: 16.9
Current: -69.6
0
16.9
3-Year EBITDA Growth Rate -72.20
SKLN's 3-Year EBITDA Growth Rate is ranked lower than
99% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. SKLN: -72.20 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
SKLN' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -72.2  Med: -37.95 Max: -14.8
Current: -72.2
-72.2
-14.8
3-Year EPS without NRI Growth Rate -72.90
SKLN's 3-Year EPS without NRI Growth Rate is ranked lower than
96% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. SKLN: -72.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
SKLN' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -72.9  Med: -36.9 Max: -17.5
Current: -72.9
-72.9
-17.5
» SKLN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with SKLN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NAS:BMRA, NAS:BLFS, NAS:BIOL, NYSE:BAX, NYSE:BDX » details
Skyline Medical Inc is an development stage company that manufactures and sells environmentally conscientious system for the collection and disposal of infectious fluids that result from surgical procedures and post-operative care.

Skyline Medical Inc, formerly known as BioDrain Medical Inc., was incorporated on April 23, 2002. The Company is a development stage medical device company manufacturing a system for the collection and disposal of infectious fluids that results from surgical procedures and post-operative care. The Company owns patent rights to products and distributes products to medical facilities where bodily and irrigation fluids produced during surgical procedures must be contained, measured, documented, and disposed. Its products minimize the exposure potential to the healthcare workers who handles such fluids. Its product, the STREAMWAY Fluid Management System, suctions surgical waste fluid from the patient using standard surgical tubing. The surgical waste fluid passes through disposable filters and into the STREAMWAY System. The STREAMWAY System maintains continuous suction to the surgical field. This simplifies the handling of fluids and will provide cost savings to facilities over the aggregate costs incurred using the traditional canister method of collection, neutralization and disposal. It sells its products through in-house sales force and intends to utilize independent distributors and manufacturer's representatives in the United States and Europe, initially, and eventually internationally. The Company competes with Cardinal Health, Inc. as well as Stryker Corporation, among others.

Ratios

vs
industry
vs
history
PB Ratio 6.51
SKLN's PB Ratio is ranked lower than
77% of the 188 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.38 vs. SKLN: 6.51 )
Ranked among companies with meaningful PB Ratio only.
SKLN' s PB Ratio Range Over the Past 10 Years
Min: 1.36  Med: 6.45 Max: 1666.67
Current: 6.51
1.36
1666.67
PS Ratio 8.29
SKLN's PS Ratio is ranked lower than
86% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.85 vs. SKLN: 8.29 )
Ranked among companies with meaningful PS Ratio only.
SKLN' s PS Ratio Range Over the Past 10 Years
Min: 0.96  Med: 20.5 Max: 5501.62
Current: 8.29
0.96
5501.62
Current Ratio 1.66
SKLN's Current Ratio is ranked lower than
73% of the 168 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. SKLN: 1.66 )
Ranked among companies with meaningful Current Ratio only.
SKLN' s Current Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.11 Max: 3.55
Current: 1.66
0.01
3.55
Quick Ratio 1.48
SKLN's Quick Ratio is ranked lower than
59% of the 168 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.64 vs. SKLN: 1.48 )
Ranked among companies with meaningful Quick Ratio only.
SKLN' s Quick Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.09 Max: 3.4
Current: 1.48
0.01
3.4
Days Inventory 541.25
SKLN's Days Inventory is ranked lower than
98% of the 158 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 126.59 vs. SKLN: 541.25 )
Ranked among companies with meaningful Days Inventory only.
SKLN' s Days Inventory Range Over the Past 10 Years
Min: 231.8  Med: 331.58 Max: 541.25
Current: 541.25
231.8
541.25
Days Sales Outstanding 31.15
SKLN's Days Sales Outstanding is ranked higher than
93% of the 142 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.07 vs. SKLN: 31.15 )
Ranked among companies with meaningful Days Sales Outstanding only.
SKLN' s Days Sales Outstanding Range Over the Past 10 Years
Min: 21.21  Med: 75.65 Max: 365
Current: 31.15
21.21
365
Days Payable 443.65
SKLN's Days Payable is ranked higher than
98% of the 129 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 49.88 vs. SKLN: 443.65 )
Ranked among companies with meaningful Days Payable only.
SKLN' s Days Payable Range Over the Past 10 Years
Min: 441.21  Med: 2076.82 Max: 42444.29
Current: 443.65
441.21
42444.29

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -186.50
SKLN's 3-Year Average Share Buyback Ratio is ranked lower than
98% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.70 vs. SKLN: -186.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
SKLN' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -186.5  Med: -98.55 Max: -61.3
Current: -186.5
-186.5
-61.3

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 35.50
SKLN's Price-to-Net-Cash is ranked lower than
81% of the 52 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 15.38 vs. SKLN: 35.50 )
Ranked among companies with meaningful Price-to-Net-Cash only.
SKLN' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 4.63  Med: 25.65 Max: 46.67
Current: 35.5
4.63
46.67
Price-to-Net-Current-Asset-Value 8.19
SKLN's Price-to-Net-Current-Asset-Value is ranked lower than
53% of the 116 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.51 vs. SKLN: 8.19 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
SKLN' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 4  Med: 7.39 Max: 10.77
Current: 8.19
4
10.77
Price-to-Tangible-Book 7.34
SKLN's Price-to-Tangible-Book is ranked lower than
66% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.31 vs. SKLN: 7.34 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
SKLN' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.86  Med: 6.73 Max: 9.59
Current: 7.34
3.86
9.59
Price-to-Median-PS-Value 0.40
SKLN's Price-to-Median-PS-Value is ranked higher than
89% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. SKLN: 0.40 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
SKLN' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.39  Med: 1.43 Max: 3.52
Current: 0.4
0.39
3.52
Earnings Yield (Greenblatt) % -57.47
SKLN's Earnings Yield (Greenblatt) % is ranked lower than
97% of the 230 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.20 vs. SKLN: -57.47 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
SKLN' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -63.69  Med: 0 Max: 2601.9
Current: -57.47
-63.69
2601.9

More Statistics

Revenue (TTM) (Mil) $0.46
EPS (TTM) $ -4.06
Beta0.46
Short Percentage of Float21.04%
52-Week Range $1.52 - 7.25
Shares Outstanding (Mil)4.56
» More Articles for NAS:SKLN

Headlines

Articles On GuruFocus.com

More From Other Websites
SKYLINE MEDICAL INC. Financials Mar 22 2017
Skyline Medical, Inc. :SKLN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Mar 20 2017
Skyline Medical, Inc. :SKLN-US: Earnings Analysis: 2016 By the Numbers : March 20, 2017 Mar 20 2017
SKYLINE MEDICAL INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 15 2017
Skyline Medical Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Business... Mar 15 2017
SKYLINE MEDICAL INC. Files SEC form 10-K, Annual Report Mar 15 2017
Skyline Medical to Hold Business Update Conference Call on March 15, 2017 Mar 09 2017
4 Biopharma Stocks Moving the Market on Wednesday Mar 01 2017
Skyline Medical Awarded Innovative Technology Contract from Vizient, Inc. for STREAMWAY® System Mar 01 2017
SKYLINE MEDICAL INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 22 2017
Skyline Medical Announces Exercise of Over-Allotment Option by Underwriter Feb 22 2017
Skyline Medical, Inc. Compliant with All Nasdaq Listing Criteria Feb 17 2017
SKYLINE MEDICAL INC. Files SEC form 8-K, Other Events Jan 31 2017
SKYLINE MEDICAL INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Jan 27 2017
Skyline Medical Stockholders Approve Proposal to Increase Shares Outstanding Jan 26 2017
Dawson James Securities Announces the Completion of Registered Direct Offering with Skyline Medical... Jan 19 2017
Skyline Medical Announces Pricing of Public Offering of Common Stock and Warrants Jan 13 2017
Skyline Medical to Hold Business Update Conference Call on January 19, 2017 Jan 12 2017
SKYLINE MEDICAL INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Dec 29 2016
Skyline Medical Receives Requested Extension from Nasdaq Panel Dec 29 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)